Scholarlink

<p>CYLD is a functional deubiquitinase, involved in the regulation of significant cellular functions, including survival and apoptosis. To elucidate the role of CYLD in B cell differentiation, we generated transgenic animals with targeted deletion of the catalytically active form of the protein in B cells, starting from early differentiation stages. Our results indicate that catalytic inactivation of CYLD leads to a severe reduction of mature B cells, associated with blockade of differentiation at the Pro B cell stage, altered distribution of B cell populations in the spleen and bone marrow, culminating in impaired immune responses to model antigens. Single cell RNA sequencing of bone marrow B cells confirmed the severe perturbation of lymphopoiesis. Mechanistically, we found impaired expression of the IL-7 receptor alpha chain (IL-7Ra) and its upstream transcriptional activator FOXO1, leading to defective IL-7 signaling that is vital for early B cell development. However, the substrate(s) deubiquitinated by CYLD that regulates the FOXO1-IL-7R pathway remains unclear. Overall, our data imply a crucial role for the deubiquitinase activity of CYLD in B cell lymphopoiesis.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The deubiquitinase activity of CYLD is required for B cell differentiation

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月8日

查看全文
  • Athanasios Pseftogas,
  • Jessica Bordini,
  • George Gavriilidis,
  • Michela Frenquelli,
  • Alessandro Campanella,
  • Alessandra Rovida,
  • Gaia Morello,
  • Marina Gerousi,
  • Eleni Theodosiou,
  • Styliani-Christina Fragkouli,
  • Vasileios Vasileiou,
  • Theodoros Sklaviadis,
  • Dimitra Dafou,
  • George Mosialos,
  • Claudio Tripodo,
  • Fotis Psomopoulos,
  • Thomas H. Winkler,
  • Kostas Stamatopoulos,
  • Paolo Ghia,
  • Konstantinos Xanthopoulos

摘要

CYLD is a functional deubiquitinase, involved in the regulation of significant cellular functions, including survival and apoptosis. To elucidate the role of CYLD in B cell differentiation, we generated transgenic animals with targeted deletion of the catalytically active form of the protein in B cells, starting from early differentiation stages. Our results indicate that catalytic inactivation of CYLD leads to a severe reduction of mature B cells, associated with blockade of differentiation at the Pro B cell stage, altered distribution of B cell populations in the spleen and bone marrow, culminating in impaired immune responses to model antigens. Single cell RNA sequencing of bone marrow B cells confirmed the severe perturbation of lymphopoiesis. Mechanistically, we found impaired expression of the IL-7 receptor alpha chain (IL-7Ra) and its upstream transcriptional activator FOXO1, leading to defective IL-7 signaling that is vital for early B cell development. However, the substrate(s) deubiquitinated by CYLD that regulates the FOXO1-IL-7R pathway remains unclear. Overall, our data imply a crucial role for the deubiquitinase activity of CYLD in B cell lymphopoiesis.